Enter inventor name

Daniel E Kahne

This inventor holds 31 USPTO granted patents and 1 EPO patent, primarily in Glycopeptide Antibiotics. Top assignees: Princeton University, Harvard College, Transcell Technologies, Inc.. Active years: 1994-2023.

USPTO Granted Patents = 31

% Patents Active = 80.6

EPO Patents = 1

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 342(Granted Patents)

Location History:

Princeton, NJ (US) (1994 - 2009)
Cambridge, MA (US) (2021)
Brookline, MA (US) (2013 - 2023)

Company Filing History:

Transcell Technologies, Inc.

patents

4. 1 out of 1,577

The Ohio State University

patents

where one patent can have more than one assignee

Years Active: 1994-2023

Loading Chart...

Areas of Expertise:

Glycopeptide Antibiotics

TRNA Synthetase Inhibitors

Glycosylation Method

Aminocoumarin Compounds

Modified Lipopolysaccharide

Moenomycin Analogs

Glycosyltransferase Inhibitors

Antibacterial Compounds

Pharmaceutical Compositions

Catalytic Method

Glycosidic Linkages

High-Throughput Screen

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11713335 - Aminocoumarin compounds and methods of their use (2023-08-01),

2. 11261201 - TRNA synthetase inhibitors (2022-03-01),

3. 11191773 - Methods of treatment for bacterial infections (2021-12-07),

4. 10864266 - Modified lipopolysaccharide glycoform and method of use (2020-12-15),

5. 10525126 - Modified lipopolysaccharide glycoform and method of use (2020-01-07),

6. 10106833 - Methods and compounds for identifying glycosyltransferase inhibitors (2018-10-23),

7. 9902985 - Chemoenzymatic methods for synthesizing moenomycin analogs (2018-02-27),

8. 9677052 - Modified lipopolysaccharide glycoform and method of use (2017-06-13),

9. 9273084 - Moenomycin analogs, methods of synthesis, and uses thereof (2016-03-01),

10. 8604004 - Moenomycin analogs, methods of synthesis, and uses thereof (2013-12-10),

11. 7473671 - Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same (2009-01-06),

12. 7344850 - Identification of active-site inhibitors of glycosyltransferases using a generalizable high-throughput screen (2008-03-18),

13. 7331920 - Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same (2008-02-19),

14. 6841661 - Glycopeptide antibacterial compounds, compositions containing same and methods of using same (2005-01-11),

15. 6710168 - Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same (2004-03-23),

Title: The Innovations of Daniel E. Kahne

Introduction

Daniel E. Kahne, based in Princeton, NJ, is a notable innovator and inventor with a remarkable portfolio of 31 patents. His work primarily focuses on pharmaceutical compositions and methods targeting Gram-negative bacterial infections, significantly contributing to advancements in the field of microbiology and therapeutic development.

Latest Patents

Among his latest patents, Kahne has developed aminocoumarin compounds that are aimed at treating Gram-negative bacterial infections. These compounds, along with their associated pharmaceutical compositions, offer promising methods for medical treatments. Another significant invention is related to tRNA synthetase inhibitors, where secondary amine compounds were disclosed to effectively inhibit tRNA synthetase in Gram-negative bacteria. This invention not only shows potential in combating Gram-negative bacterial infections but also presents a new avenue in the treatment of tuberculosis.

Career Highlights

Kahne's career is highlighted by his association with prestigious institutions such as Princeton University and the President and Fellows of Harvard College. His tenure in these institutions has allowed him to contribute to groundbreaking research and innovation in the field of chemistry and medicine.

Collaborations

Throughout his career, Kahne has worked alongside talented individuals, including Suzanne Walker Kahne. These collaborations have likely played a significant role in his innovations and the successful implementation of his patented technologies.

Conclusion

Daniel E. Kahne stands as a prominent figure in the landscape of innovation, with his extensive patent portfolio underscoring his contributions to medical science and pharmaceuticals. His work continues to influence the development of treatments for serious bacterial infections, showcasing the integral role of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]